Your search for esrd returned 70 results

Your search for esrd returned 70 results

Sort Results:

Relevant Recent
Drugs in the Pipeline

Phase 3 Long-Term Study of Zerenex for Hyperphosphatemia in ESRD

Keryx Biopharmaceuticals announced top-line results from the long-term Phase 3 study of Zerenex (ferric citrate), for the treatment of elevated serum phosphorus levels, or hyperphosphatemia, in patients with end-stage renal disease (ESRD) on dialysis.
Drug News

Kidney Stones Increase Risk of Adverse Kidney Outcomes

Kidney stones correlate with an increased risk of adverse kidney outcomes, including end-stage renal disease (ESRD), Stage 3b-5 chronic kidney disease, and sustained doubling of serum creatinine, but increases in absolute rates are small.